These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21600519)

  • 21. Plasma phospholipid transfer protein activity is inversely associated with betaine in diabetic and non-diabetic subjects.
    Dullaart RP; Garcia E; Jeyarajah E; Gruppen EG; Connelly MA
    Lipids Health Dis; 2016 Aug; 15(1):143. PubMed ID: 27581838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations.
    Holleboom AG; Kuivenhoven JA; Peelman F; Schimmel AW; Peter J; Defesche JC; Kastelein JJ; Hovingh GK; Stroes ES; Motazacker MM
    Hum Mutat; 2011 Nov; 32(11):1290-8. PubMed ID: 21901787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased activity of lecithin:cholesterol acyltransferase during short-term oral estrogen progestin replacement therapy in a group of postmenopausal women.
    Ulloa N; Verdugo C; Rios M; Sepúlveda J; Sepúlveda S; Naveas R; Calvo C
    Metabolism; 1998 Mar; 47(3):297-300. PubMed ID: 9500566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of serum cholesterol esterification rates on the development of diabetes mellitus in a general population.
    Tanaka SI; Fujioka Y; Tsujino T; Ishida T; Hirata KI
    Lipids Health Dis; 2018 Jul; 17(1):180. PubMed ID: 30055622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma levels of Apolipoprotein A1 and Lecithin:Cholesterol Acyltransferase in type 2 diabetes mellitus: Correlations with haptoglobin phenotypes.
    Awadallah S; Madkour M; Hamidi RA; Alwafa EA; Hattab M; Zakkour B; Al-Matroushi A; Ahmed E; Al-Kitbi M
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S543-S546. PubMed ID: 28416369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes induces gender gap on LCAT levels and activity.
    Nakhjavani M; Morteza A; Karimi R; Banihashmi Z; Esteghamati A
    Life Sci; 2013 Jan; 92(1):51-4. PubMed ID: 23142243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
    Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
    Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of N-linked glycosylation of lecithin:cholesterol acyltransferase in lipoprotein substrate specificity.
    O K; Hill JS; Pritchard PH
    Biochim Biophys Acta; 1995 Jan; 1254(2):193-7. PubMed ID: 7827124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families.
    Calabresi L; Pisciotta L; Costantin A; Frigerio I; Eberini I; Alessandrini P; Arca M; Bon GB; Boscutti G; Busnach G; Frascà G; Gesualdo L; Gigante M; Lupattelli G; Montali A; Pizzolitto S; Rabbone I; Rolleri M; Ruotolo G; Sampietro T; Sessa A; Vaudo G; Cantafora A; Veglia F; Calandra S; Bertolini S; Franceschini G
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1972-8. PubMed ID: 15994445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carriers of lecithin cholesterol acyltransferase gene mutations have accelerated atherogenesis as assessed by carotid 3.0-T magnetic resonance imaging [corrected].
    Duivenvoorden R; Holleboom AG; van den Bogaard B; Nederveen AJ; de Groot E; Hutten BA; Schimmel AW; Hovingh GK; Kastelein JJ; Kuivenhoven JA; Stroes ES
    J Am Coll Cardiol; 2011 Dec; 58(24):2481-7. PubMed ID: 22133847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.
    Holleboom AG; Daniil G; Fu X; Zhang R; Hovingh GK; Schimmel AW; Kastelein JJ; Stroes ES; Witztum JL; Hutten BA; Tsimikas S; Hazen SL; Chroni A; Kuivenhoven JA
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3066-75. PubMed ID: 23023370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147 --> Trp) and LCAT (Tyr171 --> Stop).
    Guerin M; Dachet C; Goulinet S; Chevet D; Dolphin PJ; Chapman MJ; Rouis M
    Atherosclerosis; 1997 May; 131(1):85-95. PubMed ID: 9180249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase activities in hispanic and anglo postmenopausal women: associations with total and regional body fat.
    Greaves KA; Going SB; Fernandez ML; Milliken LA; Lohman TG; Bassford T; McNamara DJ
    Metabolism; 2003 Mar; 52(3):282-9. PubMed ID: 12647264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a new LCAT mutation causing familial LCAT deficiency (FLD) and the role of APOE as a modifier gene of the FLD phenotype.
    Baass A; Wassef H; Tremblay M; Bernier L; Dufour R; Davignon J
    Atherosclerosis; 2009 Dec; 207(2):452-7. PubMed ID: 19515369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of high density lipoprotein composition to plasma lecithin:cholesterol acyltransferase concentration in men.
    Miller NE; Rajput-Williams J; Nanjee MN; Samuel L; Albers JJ
    Atherosclerosis; 1988 Feb; 69(2-3):123-9. PubMed ID: 3126747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased risk of premature coronary artery disease in Egyptians with ABCA1 (R219K), CETP (TaqIB), and LCAT (4886C/T) genes polymorphism.
    Abd El-Aziz TA; Mohamed RH; Hagrass HA
    J Clin Lipidol; 2014; 8(4):381-9. PubMed ID: 25110219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel LCAT (Lecithin:Cholesterol Acyltransferase) Activator DS-8190a Prevents the Progression of Plaque Accumulation in Atherosclerosis Models.
    Sasaki M; Delawary M; Sakurai H; Kobayashi H; Nakao N; Tsuru H; Fukushima Y; Honzumi S; Moriyama S; Wada N; Kaneko T; Yamada K; Terasaka N; Kubota K
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):360-376. PubMed ID: 33086872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single nucleotide polymorphisms in LCAT may contribute to dyslipidaemia in HIV-infected individuals on HAART in a Ghanaian population.
    Bani SB; Danquah KO; Obirikorang C; Owiredu WKBA; Quaye L; Muonir Der E; Acheampong E; Adams Y; Dapare PPM; Banyeh M; Anto EO; Sakyi SA
    Sci Rep; 2020 Nov; 10(1):19419. PubMed ID: 33173066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met).
    Klein HG; Lohse P; Pritchard PH; Bojanovski D; Schmidt H; Brewer HB
    J Clin Invest; 1992 Feb; 89(2):499-506. PubMed ID: 1737840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel LCAT mutation (Phe382-->Val) in a kindred with familial LCAT deficiency and defective apolipoprotein B-100.
    Nanjee MN; Stocks J; Cooke CJ; Molhuizen HO; Marcovina S; Crook D; Kastelein JP; Miller NE
    Atherosclerosis; 2003 Sep; 170(1):105-13. PubMed ID: 12957688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.